| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |